SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-21-000221
Filing Date
2021-11-04
Accepted
2021-11-04 16:21:57
Documents
15
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bgne-20211104.htm   iXBRL 8-K 46807
2 EX-99.1 exhibit991-q32021earningsr.htm EX-99.1 142702
3 EX-99.2 exhibit992-ashcurtainraise.htm EX-99.2 58431
7 bgnenewlogo2.jpg GRAPHIC 16225
  Complete submission text file 0001651308-21-000221.txt   443093

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20211104.xsd EX-101.SCH 1996
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20211104_lab.xml EX-101.LAB 25214
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20211104_pre.xml EX-101.PRE 13249
8 EXTRACTED XBRL INSTANCE DOCUMENT bgne-20211104_htm.xml XML 11525
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 211380354
SIC: 2834 Pharmaceutical Preparations